Slideshow
Author(s):
New research found over a quarter of children with treatment-refractory epilepsy sustained treatment response to CBD over four years.
This Week on NeurologyLive® — October 28, 2024
Episode 123: Previewing Cleveland Clinic's Epilepsy Summit
NeurologyLive® Brain Games: October 20, 2024
Episode 116: Understanding Vorasidenib's Therapeutic Benefit on Neurocognition, Seizure Control in Diffuse Gliomas
This Week on NeurologyLive® — October 7, 2024
NeurologyLive® Friday 5 — October 4, 2024